化工社化工社 化学情報印刷レポート · 研究参考用
HRID 2088921作成日:2026年10月25日
Sodium Carbonate → tert-butyl 4-[4-(3,6-dihydro-2H-pyran-4-yl)-1-(2-pyrrolidin-1-ylethyl)imidazol-2-yl]piperidine-1-carboxylate
https://huagongshe.com/reaction/2088921
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Sodium Carbonate | HCID 10340 | — |
| 反応物 | Tri-tert-butylphosphine tetrafluoroborate | HCID 2734635 | — |
| 反応物 | 3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester | HCID 11218053 | — |
| 反応物 | Tert-butyl 4-[4-iodo-1-(2-pyrrolidin-1-ylethyl)imidazol-2-yl]piperidine-1-carboxylate | HCID 67112018 | — |
| 触媒 | palladium(II) acetate | HCID 167845 | — |
| 溶媒 | Dimethyl Sulfoxide | HCID 679 | — |
| 溶媒 | Water | HCID 962 | — |
| 溶媒 | tert-Butyl methyl ether | HCID 15413 | — |
| 生成物 | tert-butyl 4-[4-(3,6-dihydro-2H-pyran-4-yl)-1-(2-pyrrolidin-1-ylethyl)imidazol-2-yl]piperidine-1-carboxylate | HCID 67112253 | 96.3% |
反応手順
Combine 2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (19.1 g, 1.6 eq), tert-butyl 4-[4-iodo-1-(2-pyrrolidin-1-ylethyl)imidazol-2-yl]piperidine-1-carboxylate (27 g, 56.9 mmol), sodium carbonate (120.6 g, 3.0 eq), and dimethyl sulfoxide (135 mL). Stir for five minutes. Add tri-tert-butylphosphonium tetrafluoroborate (1.7 g, 0.1 eq) and palladium(II) acetate (645.4 mg, 0.05 eq). Stir the resulting suspension at 75-80° C. under nitrogen for 45 minutes. Allow the mixture to cool to room temperature, then dilute with water (190 mL) and methyl tert-butyl ether (80 mL). Wash the aqueous layer with methyl tert-butyl ether (3×54 mL). Wash the organics with water (60 mL) and then with a 10% w/w aqueous solution of phosphoric acid (60 mL, 20 mL). Combine these aqueous layers and wash them with methyl tert-butyl ether (60 mL). Add sodium carbonate to the acidic aqueous layer to adjust the pH to 12. Wash the basic aqueous layer with methyl tert-butyl ether (120 mL, 30 mL). Wash the combined organics with aqueous saturated sodium chloride, dry over anhydrous magnesium sulfate, and concentrate in vacuo to give tert-butyl 4-[4-(3,6-dihydro-2H-pyran-4-yl)-1-(2-pyrrolidin-1-ylethyl)imidazol-2-yl]piperidine-1-carboxylate (23.6 g, 96%). MS (ES) m/z=431 [M]+.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US08436002B2 |
|---|
| 出典データセット | uspto-grants-2013_05 |
|---|
| ORD ID | ord-373a90f4c0d447c08f48ebe43527dfdb |
|---|
| 出典メモ | uspto-grants-2013_05 |
|---|